title: A microfluidic chip platform with electrochemical carbon nanotube electrodes for pre-clinical evaluation of antibiotics nanocapsules.
abstract: This paper presents a microfluidic chip platform with electrochemical carbon nanotube electrodes for preclinical evaluation of antibiotics nanocapsules. Currently, there has been an increasing interest in the development of nanocapsules for drug delivery applications for localized treatments of diseases. So far, the methods to detect antibiotics are liquid chromatography (LC), high performance liquid chromatography (HPLC), mass spectroscopy (MS). These conventional instruments are bulky, expensive, not ease of access, and talented operator required. In order to help the development of nanocapsules and understand drug release profile before planning the clinical experiments, it is important to set up a biosensing platform which could monitor and evaluate the real-time drug release profile of nanocapsules with high sensitivity and long-term measurement ability. In this work, a microfluidic chip platform with electrochemical carbon nanotube electrodes has been developed and characterized for rapid detection of antibiotics teicoplanin nanocapsules. Multi-walled carbon nanotubes are used to modify the gold electrode surfaces to enhance the performance of the electrochemical biosensors. Experimental results show that the limit of detection of the developed platform using carbon nanotubes electrodes is 0.1 μg/ml with a linear range from 1 μg/ml to 10 μg/ml. The sensitivity of the developed system is 0.023 mA ml/μg at 37°C. The drug release profile of teicoplanin nanocapsules in PBS shows that the antibiotics nanocapsules significantly increased the release of drug on the 4th day, measuring 0.4858 μg/(ml hr). The release of drug from the antibiotics nanocapsules reached 34.98 μg/ml on the 7th day. The results showed a similar trend compared with the measurement result using the HPLC instrument. Compared with the traditional HPLC measurements, the electrochemical sensing platform we developed measures results with increased flexibility in controlling experimental factors for long-term preclinical measurement of nanocapsules in real time and at low cost.
authors.affiliation: Department of Power Mechanical Engineering, National Tsing Hua University, Hsinchu, Taiwan. chong@pme.nthu.edu.tw
authors.forename: Chien-Chong
authors.initials: CC
authors.lastname: Hong
authors.forename: Chih-Ying
authors.initials: CY
authors.lastname: Wang
authors.forename: Kuo-Ti
authors.initials: KT
authors.lastname: Peng
authors.forename: I-Ming
authors.initials: IM
authors.lastname: Chu
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000032:analysis*; D015374:Biosensing Techniques / Q000295:instrumentation*; D002851:Chromatography, High Pressure Liquid; D004563:Electrochemistry; D004566:Electrodes; D046210:Microfluidic Analytical Techniques / Q000295:instrumentation*; D053769:Nanocapsules; D037742:Nanotubes, Carbon / Q000737:chemistry*; D017334:Teicoplanin / Q000032:analysis*
chemical_list: D000900:Anti-Bacterial Agents; D053769:Nanocapsules; D037742:Nanotubes, Carbon; D017334:Teicoplanin